ArticleBreast care (Basel, Switzerland)2017

Evaluation of QTc Interval Prolongation in Breast Cancer Patients after Treatment with Epirubicin, Cyclophosphamide, and Docetaxel and the Influence of Interobserver Variation.

Julian Puppe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.